Here’s why a wellness platform is announcing a clinical study on supporting fibroids with Chinese medicine to address a major gap in women’s health.

Key Points Penumbra topped analyst forecasts with $339.5 million in GAAP revenue and $0.86 non-GAAP EPS, driven by double-digit U.S. thrombectomy growth. Gross margin (GAAP) expanded sharply to 66.0%, ...

In the preceding three months, 7 analysts have released ratings for Penumbra PEN, presenting a wide array of perspectives ...

If you’re suffering from osteoarthritis or chronic knee pain, Genicular Artery Embolization (GAE) might be the solution you ...

Shares of medical device company Penumbra (NYSE:PEN) jumped 11.8% in the afternoon session after the company reported impressive second-quarter financial results that surpassed analyst expectations ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second ...

Explore Penumbra's Q2 2025 earnings highlights, featuring 13.4% growth, U.S. thrombectomy success, RUBY XL launch insights, and updated revenue guidance.

People are often fixated on First lady Melania Trump and her appearance. But a resurfaced photograph from her modeling days has left social media users ...

Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its ...

Embolx, a developer of microcatheters for targeted embolization procedures, announced the market release of its ...

An Essex County surgeon is facing a seven-year suspension of his medical license after three of his patients suffered severe ...

Ultrasound, CT, and MRI are noninvasive imaging techniques used in the evaluation of PeVD. Catheter venography is another ...